Structure

Physi-Chem Properties

Molecular Weight:  300.1
Volume:  302.415
LogP:  3.477
LogD:  3.223
LogS:  -3.914
# Rotatable Bonds:  3
TPSA:  68.15
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.725
Synthetic Accessibility Score:  2.437
Fsp3:  0.176
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.889
MDCK Permeability:  2.4208366085076705e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.022
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.005

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.021
Plasma Protein Binding (PPB):  90.37635040283203%
Volume Distribution (VD):  0.636
Pgp-substrate:  12.74748706817627%

ADMET: Metabolism

CYP1A2-inhibitor:  0.957
CYP1A2-substrate:  0.959
CYP2C19-inhibitor:  0.442
CYP2C19-substrate:  0.487
CYP2C9-inhibitor:  0.46
CYP2C9-substrate:  0.933
CYP2D6-inhibitor:  0.722
CYP2D6-substrate:  0.899
CYP3A4-inhibitor:  0.446
CYP3A4-substrate:  0.261

ADMET: Excretion

Clearance (CL):  11.381
Half-life (T1/2):  0.714

ADMET: Toxicity

hERG Blockers:  0.048
Human Hepatotoxicity (H-HT):  0.034
Drug-inuced Liver Injury (DILI):  0.601
AMES Toxicity:  0.607
Rat Oral Acute Toxicity:  0.36
Maximum Recommended Daily Dose:  0.615
Skin Sensitization:  0.921
Carcinogencity:  0.07
Eye Corrosion:  0.13
Eye Irritation:  0.969
Respiratory Toxicity:  0.58

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC266006

Natural Product ID:  NPC266006
Common Name*:   Plicatol A
IUPAC Name:   4,9,10-trimethoxyphenanthrene-2,5-diol
Synonyms:  
Standard InCHIKey:  DRZYTLJQXLHYME-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C17H16O5/c1-20-13-8-9(18)7-11-15(13)14-10(5-4-6-12(14)19)16(21-2)17(11)22-3/h4-8,18-19H,1-3H3
SMILES:  COc1c(OC)c2cc(O)cc(c2c2c1cccc2O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL438339
PubChem CID:   44445445
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives
        • [CHEMONTID:0003007] Phenanthrols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. PMID[11575955]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota stems Yunnan Province, China 2004 PMID[17253844]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota Stems purchased from Kyoungdong Oriental Herbal Market, Seoul, Korea 2006-APR PMID[18052323]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota Stems n.a. n.a. PMID[27310249]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO3894 Dendrobium nobile Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[542548]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC266006 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9848 High Similarity NPC308768
0.9848 High Similarity NPC12668
0.9773 High Similarity NPC220344
0.9773 High Similarity NPC275061
0.9773 High Similarity NPC218131
0.9773 High Similarity NPC105847
0.9773 High Similarity NPC132804
0.9773 High Similarity NPC243996
0.9773 High Similarity NPC243759
0.9701 High Similarity NPC175838
0.9697 High Similarity NPC151656
0.9697 High Similarity NPC56329
0.9697 High Similarity NPC230919
0.9697 High Similarity NPC200935
0.9697 High Similarity NPC242715
0.9697 High Similarity NPC266453
0.9697 High Similarity NPC22902
0.9621 High Similarity NPC202846
0.9621 High Similarity NPC30632
0.9621 High Similarity NPC143139
0.9621 High Similarity NPC205442
0.9556 High Similarity NPC183709
0.9552 High Similarity NPC73505
0.9552 High Similarity NPC295719
0.9552 High Similarity NPC34431
0.9552 High Similarity NPC165026
0.9545 High Similarity NPC294884
0.9545 High Similarity NPC200557
0.9545 High Similarity NPC69029
0.9545 High Similarity NPC241241
0.9545 High Similarity NPC158142
0.9545 High Similarity NPC111655
0.9545 High Similarity NPC108198
0.9545 High Similarity NPC10314
0.9538 High Similarity NPC149337
0.9538 High Similarity NPC471983
0.9478 High Similarity NPC212942
0.9478 High Similarity NPC79622
0.9478 High Similarity NPC29868
0.947 High Similarity NPC160697
0.947 High Similarity NPC125649
0.9403 High Similarity NPC272157
0.9403 High Similarity NPC90615
0.9403 High Similarity NPC73535
0.9403 High Similarity NPC25111
0.9403 High Similarity NPC6262
0.9403 High Similarity NPC201145
0.9398 High Similarity NPC313081
0.9333 High Similarity NPC184613
0.9328 High Similarity NPC300846
0.9328 High Similarity NPC114155
0.9328 High Similarity NPC476639
0.9318 High Similarity NPC228843
0.9308 High Similarity NPC215300
0.9308 High Similarity NPC38017
0.9281 High Similarity NPC126291
0.9254 High Similarity NPC283009
0.9254 High Similarity NPC261873
0.9242 High Similarity NPC282508
0.9231 High Similarity NPC471986
0.9231 High Similarity NPC53781
0.9214 High Similarity NPC262297
0.9197 High Similarity NPC472089
0.9191 High Similarity NPC230124
0.9191 High Similarity NPC6300
0.9191 High Similarity NPC114171
0.9185 High Similarity NPC170328
0.9185 High Similarity NPC472648
0.9185 High Similarity NPC133463
0.9185 High Similarity NPC191462
0.9185 High Similarity NPC472649
0.9185 High Similarity NPC472647
0.9185 High Similarity NPC206525
0.9179 High Similarity NPC209199
0.9179 High Similarity NPC103967
0.9173 High Similarity NPC161958
0.9173 High Similarity NPC14224
0.9167 High Similarity NPC126836
0.9154 High Similarity NPC223953
0.9154 High Similarity NPC170485
0.913 High Similarity NPC472088
0.913 High Similarity NPC470917
0.913 High Similarity NPC472087
0.9118 High Similarity NPC472646
0.9118 High Similarity NPC71465
0.9111 High Similarity NPC256262
0.9111 High Similarity NPC37410
0.9111 High Similarity NPC258780
0.9104 High Similarity NPC32778
0.9098 High Similarity NPC15543
0.9084 High Similarity NPC473221
0.9077 High Similarity NPC105031
0.9077 High Similarity NPC105718
0.9077 High Similarity NPC278955
0.9077 High Similarity NPC113495
0.9077 High Similarity NPC105925
0.9065 High Similarity NPC469630
0.9058 High Similarity NPC265075
0.9037 High Similarity NPC276026
0.9037 High Similarity NPC56764
0.9037 High Similarity NPC555
0.9037 High Similarity NPC206737
0.9037 High Similarity NPC289258
0.9037 High Similarity NPC469659
0.9037 High Similarity NPC188378
0.9037 High Similarity NPC7515
0.903 High Similarity NPC218884
0.9023 High Similarity NPC254000
0.9023 High Similarity NPC224157
0.9023 High Similarity NPC192687
0.9015 High Similarity NPC28765
0.9015 High Similarity NPC154866
0.9015 High Similarity NPC23012
0.9008 High Similarity NPC82299
0.9007 High Similarity NPC233980
0.9 High Similarity NPC228503
0.9 High Similarity NPC138248
0.9 High Similarity NPC469795
0.8986 High Similarity NPC472092
0.8986 High Similarity NPC472091
0.8986 High Similarity NPC273623
0.8986 High Similarity NPC472090
0.8971 High Similarity NPC214853
0.8971 High Similarity NPC180602
0.8971 High Similarity NPC240279
0.8971 High Similarity NPC55239
0.8947 High Similarity NPC190144
0.8944 High Similarity NPC474397
0.8939 High Similarity NPC169474
0.8939 High Similarity NPC293054
0.8939 High Similarity NPC252131
0.8939 High Similarity NPC82679
0.8939 High Similarity NPC266555
0.8939 High Similarity NPC246620
0.8939 High Similarity NPC21563
0.8939 High Similarity NPC324112
0.8939 High Similarity NPC124452
0.8939 High Similarity NPC236760
0.8939 High Similarity NPC282000
0.8939 High Similarity NPC74817
0.8939 High Similarity NPC236791
0.8939 High Similarity NPC159968
0.8923 High Similarity NPC282496
0.8923 High Similarity NPC233526
0.8913 High Similarity NPC55947
0.8913 High Similarity NPC260741
0.8913 High Similarity NPC32630
0.8913 High Similarity NPC70682
0.8905 High Similarity NPC133025
0.8897 High Similarity NPC311256
0.8889 High Similarity NPC303144
0.8889 High Similarity NPC6451
0.8889 High Similarity NPC102256
0.8881 High Similarity NPC311680
0.8881 High Similarity NPC51840
0.8881 High Similarity NPC234488
0.8881 High Similarity NPC299221
0.8873 High Similarity NPC33832
0.8865 High Similarity NPC50250
0.8865 High Similarity NPC473845
0.8865 High Similarity NPC473108
0.8864 High Similarity NPC78974
0.8864 High Similarity NPC223136
0.8864 High Similarity NPC103823
0.8864 High Similarity NPC214406
0.8864 High Similarity NPC18924
0.8864 High Similarity NPC44748
0.8864 High Similarity NPC28730
0.8857 High Similarity NPC191231
0.8849 High Similarity NPC266650
0.8841 High Similarity NPC35550
0.8841 High Similarity NPC86605
0.8841 High Similarity NPC301765
0.8841 High Similarity NPC46277
0.8841 High Similarity NPC156948
0.8841 High Similarity NPC3072
0.8824 High Similarity NPC469610
0.8815 High Similarity NPC45715
0.8815 High Similarity NPC160623
0.8815 High Similarity NPC232275
0.8815 High Similarity NPC8899
0.8815 High Similarity NPC474356
0.8815 High Similarity NPC12275
0.8806 High Similarity NPC58164
0.8806 High Similarity NPC469963
0.8806 High Similarity NPC471518
0.8806 High Similarity NPC469951
0.8806 High Similarity NPC471519
0.8806 High Similarity NPC10225
0.8803 High Similarity NPC221318
0.8803 High Similarity NPC469557
0.8803 High Similarity NPC125617
0.8797 High Similarity NPC127587
0.8797 High Similarity NPC242032
0.8794 High Similarity NPC258083
0.8788 High Similarity NPC299584
0.8788 High Similarity NPC221077
0.8788 High Similarity NPC251855
0.8788 High Similarity NPC298757
0.8788 High Similarity NPC265483

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC266006 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8667 High Similarity NPD3027 Phase 3
0.8667 High Similarity NPD4625 Phase 3
0.8497 Intermediate Similarity NPD6232 Discontinued
0.8467 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8456 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8382 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8345 Intermediate Similarity NPD1613 Approved
0.8345 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD7473 Discontinued
0.8321 Intermediate Similarity NPD4908 Phase 1
0.8116 Intermediate Similarity NPD3018 Phase 2
0.8113 Intermediate Similarity NPD5844 Phase 1
0.8092 Intermediate Similarity NPD37 Approved
0.7956 Intermediate Similarity NPD4749 Approved
0.7956 Intermediate Similarity NPD2982 Phase 2
0.7956 Intermediate Similarity NPD2983 Phase 2
0.7956 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD6234 Discontinued
0.7941 Intermediate Similarity NPD1610 Phase 2
0.7939 Intermediate Similarity NPD5283 Phase 1
0.7935 Intermediate Similarity NPD4965 Approved
0.7935 Intermediate Similarity NPD4967 Phase 2
0.7935 Intermediate Similarity NPD4966 Approved
0.7914 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7891 Intermediate Similarity NPD6674 Discontinued
0.7891 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7883 Intermediate Similarity NPD2981 Phase 2
0.7832 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7832 Intermediate Similarity NPD3620 Phase 2
0.7817 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD1548 Phase 1
0.7724 Intermediate Similarity NPD4097 Suspended
0.7708 Intermediate Similarity NPD4060 Phase 1
0.7692 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7664 Intermediate Similarity NPD4626 Approved
0.7652 Intermediate Similarity NPD228 Approved
0.7628 Intermediate Similarity NPD1934 Approved
0.7625 Intermediate Similarity NPD7199 Phase 2
0.7625 Intermediate Similarity NPD6959 Discontinued
0.7615 Intermediate Similarity NPD2342 Discontinued
0.7607 Intermediate Similarity NPD7228 Approved
0.7606 Intermediate Similarity NPD2861 Phase 2
0.758 Intermediate Similarity NPD2801 Approved
0.7554 Intermediate Similarity NPD3705 Approved
0.7548 Intermediate Similarity NPD4005 Discontinued
0.7531 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7518 Intermediate Similarity NPD6696 Suspended
0.7517 Intermediate Similarity NPD3540 Phase 1
0.75 Intermediate Similarity NPD4750 Phase 3
0.7485 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6166 Phase 2
0.7485 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD1651 Approved
0.7463 Intermediate Similarity NPD7635 Approved
0.745 Intermediate Similarity NPD3539 Phase 1
0.745 Intermediate Similarity NPD6100 Approved
0.745 Intermediate Similarity NPD6099 Approved
0.7447 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD4055 Discovery
0.7434 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1283 Approved
0.7368 Intermediate Similarity NPD3022 Approved
0.7368 Intermediate Similarity NPD3021 Approved
0.7362 Intermediate Similarity NPD7229 Phase 3
0.7358 Intermediate Similarity NPD1465 Phase 2
0.7338 Intermediate Similarity NPD5691 Approved
0.7338 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD7390 Discontinued
0.7338 Intermediate Similarity NPD1511 Approved
0.7338 Intermediate Similarity NPD7041 Phase 2
0.7338 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD1611 Approved
0.7297 Intermediate Similarity NPD3657 Discovery
0.7294 Intermediate Similarity NPD8053 Approved
0.7294 Intermediate Similarity NPD8054 Approved
0.7292 Intermediate Similarity NPD4624 Approved
0.729 Intermediate Similarity NPD2534 Approved
0.729 Intermediate Similarity NPD2533 Approved
0.729 Intermediate Similarity NPD2532 Approved
0.729 Intermediate Similarity NPD7447 Phase 1
0.7285 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD4380 Phase 2
0.7273 Intermediate Similarity NPD8651 Approved
0.7273 Intermediate Similarity NPD7124 Phase 2
0.7267 Intermediate Similarity NPD7768 Phase 2
0.7267 Intermediate Similarity NPD3882 Suspended
0.7261 Intermediate Similarity NPD1653 Approved
0.7255 Intermediate Similarity NPD7003 Approved
0.7255 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD3750 Approved
0.725 Intermediate Similarity NPD7819 Suspended
0.7248 Intermediate Similarity NPD1607 Approved
0.7244 Intermediate Similarity NPD1512 Approved
0.7239 Intermediate Similarity NPD5494 Approved
0.7231 Intermediate Similarity NPD846 Approved
0.7231 Intermediate Similarity NPD940 Approved
0.7226 Intermediate Similarity NPD7213 Phase 3
0.7226 Intermediate Similarity NPD7212 Phase 2
0.7226 Intermediate Similarity NPD4357 Discontinued
0.7225 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD3094 Phase 2
0.7222 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6559 Discontinued
0.7219 Intermediate Similarity NPD7240 Approved
0.7219 Intermediate Similarity NPD2935 Discontinued
0.7211 Intermediate Similarity NPD5109 Approved
0.7211 Intermediate Similarity NPD5110 Phase 2
0.7211 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD5111 Phase 2
0.7205 Intermediate Similarity NPD3817 Phase 2
0.7205 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD1669 Approved
0.7194 Intermediate Similarity NPD5536 Phase 2
0.719 Intermediate Similarity NPD5177 Phase 3
0.7183 Intermediate Similarity NPD1281 Approved
0.7183 Intermediate Similarity NPD422 Phase 1
0.7181 Intermediate Similarity NPD5735 Approved
0.7179 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7549 Discontinued
0.7174 Intermediate Similarity NPD6671 Approved
0.7172 Intermediate Similarity NPD6584 Phase 3
0.717 Intermediate Similarity NPD4678 Approved
0.717 Intermediate Similarity NPD4675 Approved
0.7163 Intermediate Similarity NPD2286 Discontinued
0.7154 Intermediate Similarity NPD1242 Phase 1
0.7153 Intermediate Similarity NPD1398 Phase 1
0.7152 Intermediate Similarity NPD1510 Phase 2
0.7152 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5929 Approved
0.7143 Intermediate Similarity NPD3892 Phase 2
0.7134 Intermediate Similarity NPD6746 Phase 2
0.7125 Intermediate Similarity NPD5090 Approved
0.7125 Intermediate Similarity NPD5089 Approved
0.7124 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD7340 Approved
0.7114 Intermediate Similarity NPD1240 Approved
0.7114 Intermediate Similarity NPD1558 Phase 1
0.7114 Intermediate Similarity NPD2238 Phase 2
0.7114 Intermediate Similarity NPD2979 Phase 3
0.7111 Intermediate Similarity NPD5451 Approved
0.7107 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD5408 Approved
0.7105 Intermediate Similarity NPD5405 Approved
0.7105 Intermediate Similarity NPD2438 Suspended
0.7105 Intermediate Similarity NPD5404 Approved
0.7105 Intermediate Similarity NPD5406 Approved
0.7101 Intermediate Similarity NPD7074 Phase 3
0.7097 Intermediate Similarity NPD5241 Discontinued
0.7097 Intermediate Similarity NPD2219 Phase 1
0.7095 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD4536 Approved
0.7086 Intermediate Similarity NPD4538 Approved
0.7086 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6111 Discontinued
0.7083 Intermediate Similarity NPD3818 Discontinued
0.7083 Intermediate Similarity NPD8251 Approved
0.7083 Intermediate Similarity NPD8099 Discontinued
0.7083 Intermediate Similarity NPD8252 Approved
0.7083 Intermediate Similarity NPD5327 Phase 3
0.7078 Intermediate Similarity NPD3060 Approved
0.707 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD5124 Phase 1
0.7067 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD3092 Approved
0.7059 Intermediate Similarity NPD5763 Approved
0.7059 Intermediate Similarity NPD5762 Approved
0.7055 Intermediate Similarity NPD6788 Approved
0.7055 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD709 Approved
0.7042 Intermediate Similarity NPD5125 Phase 3
0.7042 Intermediate Similarity NPD5126 Approved
0.7041 Intermediate Similarity NPD8156 Discontinued
0.7041 Intermediate Similarity NPD7054 Approved
0.7039 Intermediate Similarity NPD4108 Discontinued
0.7032 Intermediate Similarity NPD6331 Phase 2
0.7029 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD7095 Approved
0.7021 Intermediate Similarity NPD3091 Approved
0.7019 Intermediate Similarity NPD7411 Suspended
0.7014 Intermediate Similarity NPD2233 Approved
0.7014 Intermediate Similarity NPD2232 Approved
0.7014 Intermediate Similarity NPD2230 Approved
0.7013 Intermediate Similarity NPD7037 Approved
0.7012 Intermediate Similarity NPD7075 Discontinued
0.7 Intermediate Similarity NPD3226 Approved
0.7 Intermediate Similarity NPD7472 Approved
0.7 Intermediate Similarity NPD4140 Approved
0.6987 Remote Similarity NPD2677 Approved
0.6987 Remote Similarity NPD5084 Clinical (unspecified phase)
0.698 Remote Similarity NPD6798 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data